These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 8693551

  • 21. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7.
    Wu Y, Guo Y, Liu Y.
    J Exp Med; 1993 Nov 01; 178(5):1789-93. PubMed ID: 8228824
    [Abstract] [Full Text] [Related]

  • 22. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH, Zheng XG, Magee C, Hancock WW, Turka LA.
    Transplantation; 1997 Dec 27; 64(12):1646-50. PubMed ID: 9422396
    [Abstract] [Full Text] [Related]

  • 23. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, Turka LA, Russell ME, Peach R, Sayegh MH.
    Am J Pathol; 2001 Mar 27; 158(3):977-86. PubMed ID: 11238045
    [Abstract] [Full Text] [Related]

  • 24. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts.
    Truong W, Plester JC, Hancock WW, Merani S, Murphy TL, Murphy KM, Kaye J, Anderson CC, Shapiro AM.
    Am J Transplant; 2007 Dec 27; 7(12):2663-74. PubMed ID: 17983390
    [Abstract] [Full Text] [Related]

  • 25. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
    Guillot C, Mathieu P, Coathalem H, Le Mauff B, Castro MG, Tesson L, Usal C, Laumonier T, Brouard S, Soulillou JP, Lowenstein PR, Cuturi MC, Anegon I.
    J Immunol; 2000 May 15; 164(10):5258-68. PubMed ID: 10799887
    [Abstract] [Full Text] [Related]

  • 26. CTLA4Ig attenuates accelerated rejection (presensitization) in the mouse islet allograft model.
    Roy-Chaudhury P, Nickerson PW, Manfro RC, Zheng XX, Steiger J, Li YS, Strom TB.
    Transplantation; 1997 Jul 15; 64(1):172-5. PubMed ID: 9233722
    [Abstract] [Full Text] [Related]

  • 27. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
    Schaub M, Stadlbauer TH, Chandraker A, Vella JP, Turka LA, Sayegh MH.
    J Am Soc Nephrol; 1998 May 15; 9(5):891-8. PubMed ID: 9596088
    [Abstract] [Full Text] [Related]

  • 28. Prolongation of islet allograft survival by coexpression of CTLA4Ig and CD40LIg in mice.
    Li ZL, Xue WJ, Tian PX, Ding XM, Tian XH, Feng XS, Hou J.
    Transplant Proc; 2007 Dec 15; 39(10):3436-7. PubMed ID: 18089400
    [Abstract] [Full Text] [Related]

  • 29. CTLA4ig induces long-term graft survival of allogeneic skin grafts and totally inhibits T-cell proliferation in LFA-1-deficient mice.
    Malm H, Corbascio M, Osterholm C, Cowan S, Larsen CP, Pearson TC, Ekberg H.
    Transplantation; 2002 Jan 27; 73(2):293-7. PubMed ID: 11821746
    [Abstract] [Full Text] [Related]

  • 30. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A, Kishimoto K, Dong VM, Sho M, Salama AD, Anosova NG, Benichou G, Mandelbrot DA, Sharpe AH, Turka LA, Auchincloss H, Sayegh MH.
    J Immunol; 2001 Jul 01; 167(1):140-6. PubMed ID: 11418642
    [Abstract] [Full Text] [Related]

  • 31. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig.
    Yang Z, Rostami S, Koeberlein B, Barker CF, Naji A.
    Transplantation; 1999 Jun 27; 67(12):1517-23. PubMed ID: 10401757
    [Abstract] [Full Text] [Related]

  • 32. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells.
    Chahine AA, Yu M, McKernan MM, Stoeckert C, Lau HT.
    Transplantation; 1995 May 15; 59(9):1313-8. PubMed ID: 7762068
    [Abstract] [Full Text] [Related]

  • 33. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
    Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH.
    Proc Natl Acad Sci U S A; 1996 Oct 29; 93(22):12439-44. PubMed ID: 8901600
    [Abstract] [Full Text] [Related]

  • 34. Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse.
    Nabeyama K, Yasunami Y, Toyofuku A, Nakano M, Satoh M, Matsuoka N, Ono J, Kamada M, Uede T, Todo S, Ikeda S.
    Transplantation; 2004 Dec 15; 78(11):1590-6. PubMed ID: 15591946
    [Abstract] [Full Text] [Related]

  • 35. In situ protection against islet allograft rejection by CTLA4Ig transduction.
    Londrigan SL, Sutherland RM, Brady JL, Carrington EM, Cowan PJ, d'Apice AJ, O'Connell PJ, Zhan Y, Lew AM.
    Transplantation; 2010 Nov 15; 90(9):951-7. PubMed ID: 20808263
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways.
    Safley SA, Kapp LM, Tucker-Burden C, Hering B, Kapp JA, Weber CJ.
    Transplantation; 2005 Feb 27; 79(4):409-18. PubMed ID: 15729166
    [Abstract] [Full Text] [Related]

  • 37. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.
    Akalin E, Chandraker A, Russell ME, Turka LA, Hancock WW, Sayegh MH.
    Transplantation; 1996 Dec 27; 62(12):1942-5. PubMed ID: 8990393
    [Abstract] [Full Text] [Related]

  • 38. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
    Peach RJ, Bajorath J, Brady W, Leytze G, Greene J, Naemura J, Linsley PS.
    J Exp Med; 1994 Dec 01; 180(6):2049-58. PubMed ID: 7964482
    [Abstract] [Full Text] [Related]

  • 39. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.
    Chandraker A, Russell ME, Glysing-Jensen T, Willett TA, Sayegh MH.
    Transplantation; 1997 Apr 27; 63(8):1053-8. PubMed ID: 9133464
    [Abstract] [Full Text] [Related]

  • 40. Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice.
    Benda B, Ljunggren HG, Peach R, Sandberg JO, Korsgren O.
    Cell Transplant; 2002 Apr 27; 11(7):715-20. PubMed ID: 12518898
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.